Back

The role of Smarcad1 in retroviral repression in mouse embryonic stem cells

Bren, I.; Strauss, C.; Schlesinger, S.

2023-05-19 molecular biology
10.1101/2023.05.18.541392 bioRxiv
Show abstract

BackgroundMoloney murine leukemia virus (MLV) replication is suppressed in mouse embryonic stem cells (ESCs) by the Trim28-SETDB1 complex. The chromatin remodeler Smarcad1 interacts with Trim28 and was suggested to allow the deposition of the histone variant H3.3. However, the role of Trim28, H3.3, and Smarcad1 in MLV repression in ESCs still needs to be fully understood. ResultsIn this study, we used MLV to explore the role of Smarcad1 in retroviral silencing in ESCs. We show that Smarcad1 is immediately recruited to the MLV provirus. Based on the repression dynamics of a GFP-reporter MLV, our findings suggest that Smarcad1 plays a critical role in the establishment and maintenance of MLV repression, as well as other Trim28-targeted genomic loci. Furthermore, Smarcad1 is important for stabilizing and strengthening Trim28 binding to the provirus over time, and its presence around the provirus is needed for proper deposition of H3.3 on the provirus. Surprisingly, the combined depletion of Smarcad1 and Trim28 results in enhanced MLV derepression, suggesting that these two proteins may also function independently to maintain repressive chromatin states. ConclusionsOverall, the results of this study provide evidence for the crucial role of Smarcad1 in the silencing of retroviral elements in embryonic stem cells. Further research is needed to fully understand how Smarcad1 and Trim28 cooperate and their implications for gene expression and genomic stability. Take homeO_LIDepletion of Smarcad1 impairs retroviral repression. C_LIO_LISmarcad1 is necessary for proper recruitment of Trim28 and H3.3 deposition. C_LIO_LIDepleting Smarcad1 and Trim28 results in enhanced derepression of the MLV provirus. C_LI

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 16%
10.8%
2
Molecular Biology Reports
19 papers in training set
Top 0.1%
8.7%
3
Biology Open
130 papers in training set
Top 0.1%
5.0%
4
Gene
41 papers in training set
Top 0.2%
4.5%
5
Epigenetics
43 papers in training set
Top 0.2%
3.7%
6
Viruses
318 papers in training set
Top 2%
2.7%
7
BMC Genomics
328 papers in training set
Top 1%
2.7%
8
PeerJ
261 papers in training set
Top 5%
2.1%
9
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.1%
10
Genes
126 papers in training set
Top 0.7%
2.0%
11
Cell Cycle
14 papers in training set
Top 0.1%
1.8%
12
BMC Cancer
52 papers in training set
Top 1%
1.8%
13
Frontiers in Genetics
197 papers in training set
Top 4%
1.8%
14
Virology Journal
25 papers in training set
Top 0.1%
1.5%
50% of probability mass above
15
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.5%
16
Nucleic Acids Research
1128 papers in training set
Top 12%
1.5%
17
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.4%
1.4%
18
Journal of Medical Virology
137 papers in training set
Top 3%
1.3%
19
BMC Bioinformatics
383 papers in training set
Top 5%
1.3%
20
Gene Reports
13 papers in training set
Top 0.4%
1.3%
21
Heliyon
146 papers in training set
Top 3%
1.3%
22
Bioengineering
24 papers in training set
Top 0.8%
1.1%
23
Cells
232 papers in training set
Top 4%
1.1%
24
BMC Genomic Data
12 papers in training set
Top 0.1%
1.0%
25
Journal of Virology
456 papers in training set
Top 3%
1.0%
26
Biomedicines
66 papers in training set
Top 2%
0.9%
27
Annals of Translational Medicine
17 papers in training set
Top 1%
0.9%
28
Scientific Reports
3102 papers in training set
Top 70%
0.9%
29
Development, Growth & Differentiation
12 papers in training set
Top 0.1%
0.8%
30
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%